Cyclic melanocortin receptor agonist analog. Amber-vialed against photodegradation.
$48/ 10mg
Figures are illustrative of published preclinical research and are provided for orientation only. They are not claims about this product.
MT-2 is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone. Its cyclic lactam structure confers substantially greater metabolic stability than the linear parent hormone. It is supplied in amber vials because the compound is photosensitive.
Signalling pathways examined in preclinical models. Descriptive of published research directions, not claims of effect.
Characterised against the melanocortin receptor family, with binding profiles studied across MC1R and MC4R in receptor-expressing cell lines.
The lactam bridge constrains the peptide backbone, which is the structural basis for its resistance to enzymatic degradation relative to the linear hormone.
Used as a characterised reference ligand in melanocortin receptor binding and selectivity work.
Applied in in-vitro melanocyte preparations examining melanogenesis markers.
Illustrative of published preclinical findings. Not a representation of this product’s performance, and not a claim of any effect in humans.
HPLC purity
RP-HPLC, 214 nm
Identity
LC-MS
Endotoxin (LAL)
Kinetic chromogenic
Heavy metals
ICP-MS
Net peptide content
Nitrogen analysis
Residual solvents
Headspace GC
Lot LP-2601-D
MT-2 is photosensitive. Amber glass and light-protected storage prevent photodegradation, which would otherwise show up as a rising impurity profile on reassay.
Store the sealed vial at −20°C for long-term stability and 2–8°C for short-term handling. Protect from light and avoid repeated freeze-thaw cycles. Compound-specific stability data is printed on the certificate of analysis supplied with the lot.
This material is supplied as a reference standard for in-vitro laboratory research only. It has not been evaluated by the FDA, is not a drug, and is not intended for human or veterinary use. Handling should follow your institution's chemical hygiene plan, including appropriate PPE and documented disposal.
Independent published research relating to this compound. Listed for reference; Lumen Peptides, Inc. is not affiliated with these authors and makes no claims based on their findings.
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide
Dorr RT et al. · 1996 · Life Sciences
Melanocortin peptide therapeutics
Hadley ME, Dorr RT · 2006 · Peptides
For laboratory research use only. All compounds listed on this site are sold strictly as reference materials for in-vitro laboratory research conducted by qualified professionals. They are not drugs, foods, cosmetics, or medical devices. They are not intended for human or veterinary consumption, therapeutic use, diagnostic application, or any in-vivo use whatsoever. These statements have not been evaluated by the Food and Drug Administration. By purchasing, you affirm that you are a qualified researcher and that you will comply with all applicable institutional, local, state and federal regulations governing the handling of research chemicals.
Compounds supplied through this catalog are reference materials for in-vitro laboratory research. Confirm your status to continue.
HELLO STIO 👋
Hey handsome — I built you a website.
— Rob
By entering you agree to our Terms & Research-Use Policy. These products have not been evaluated by the FDA and are not for human consumption. © 2026 Lumen Peptides, Inc.
Analytics cookies
We’d like to measure how the catalog is used, which sets cookies and shares activity with Meta. Nothing loads until you choose, and declining does not affect your order. Privacy policy